Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Children aged ≥6 months to <3 years only

Registered for use in infants and children aged 6 months to <3 years.

Quadrivalent inactivated influenza vaccine

Each 0.25 mL monodose pre-filled syringe contains:

  • 7.5 µg haemagglutinin of each of the 4 recommended influenza virus strains
  • ≤50 µg formaldehyde
  • ≤125 µg octoxinol 9
  • ≤0.5 µg ovalbumin

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018